ZIMMER BIOMET HOLDINGS, INC.

ZBH · Mid cap · 0 articles

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$8.2B	$7.7B	$7.4B	$6.9B	$6.8B
Cost of revenue	$2.5B	$2.2B	$2.1B	$2.0B	$2.0B
Selling, general & administrative	$3.3B	$2.9B	$2.8B	$2.8B	$2.8B
Research and development	$458.5M	$437.4M	$458.7M	$406.0M	$435.8M
Operating income	$1.1B	$1.3B	$1.3B	$696.3M	$860.3M
Pretax income	$830.8M	$1.0B	$1.1B	$403.5M	$499.0M
Income tax expense	$125.7M	$131.4M	$42.2M	$112.3M	$53.5M
Net income	$705.1M	$903.8M	$1.0B	$231.4M	$401.6M
Balance Sheet
Cash and equivalents	$591.9M	$525.5M	$415.8M	$375.7M	$378.1M
Current assets	$5.1B	$4.7B	$4.6B	$4.4B	$4.9B
Total assets	$23.1B	$21.4B	$21.5B	$21.1B	$23.5B
Current liabilities	$2.6B	$2.5B	$2.9B	$2.4B	$3.5B
Total liabilities	$10.4B	$8.9B	$9.0B	$9.0B	$10.8B
Total debt	—	—	$5.8B	$5.7B	$7.1B
Stockholders' equity	$12.7B	$12.5B	$12.5B	$12.0B	$12.7B
Cash Flow Statement
Cash from operations	$1.7B	$1.5B	$1.6B	$1.4B	$1.5B
Depreciation and amortization	$1.1B	$996.3M	$951.7M	$926.4M	$937.7M
Stock-based compensation	$90.2M	$101.0M	$99.8M	$105.0M	$76.0M
Capital expenditure	$224.5M	$203.8M	$291.1M	$187.9M	$143.6M
Free cash flow	$1.5B	$1.3B	$1.3B	$1.2B	$1.4B
Dividends paid	$190.3M	$196.0M	$200.9M	$201.2M	$200.1M
Share repurchases	$487.0M	$868.0M	$692.2M	$126.4M	—
Impairments	$0	$0	$0	$289.8M	$0

Shares outstanding 193.5M · Free float 68.9%

Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.